Jonathan James Major pharmaceutical companies like AstraZeneca and GlaxoSmithKline (GSK) invested a staggering 140 billion US dollars between 1997 and 2011 in drug research and development. The cost to the consumer also varies widely, with the drug Copaxone (used to treat multiple sclerosis) costing nearly $4,000 a dose in the US, compared to just $862 … Continue reading Why Do So Many Drugs Fail?
Jonathan James For a long time, the much discussed idea of editing human embryos to eradicate genetic defects has been seen as something of an extremely controversial pipe dream. Until recently, scientists had been unable to successfully edit the genome of a human embryonic cell, both for scientific and ethical reasons. That is until recently, … Continue reading Editing Human Embryos: The Science And The Ethics